Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124]
Seitz, Stephan, Buchholz, Stefan, Schally, Andrew V., Jayakumar, Arumugam R., Weber, Florian, Papadia, Andrea, Rick, Ferenc G., Szalontay, Luca, Treszl, Andrea, Köster, Frank, Ortmann, Olaf, Hohla, FlVolume:
24
Language:
english
Journal:
Anti-Cancer Drugs
DOI:
10.1097/cad.0b013e32835a7e29
Date:
February, 2013
File:
PDF, 686 KB
english, 2013